Skip to main content
. 2017 Aug 30;2(4):624–629. doi: 10.1016/j.adro.2017.08.013

Table 1.

Participant and treatment characteristics

Characteristic n (%)
Total analyzed (% Total) 53 (65.4)
Participant Characteristics
Median age, years (range) 49 (20-84)
Sex (Male) 26 (49.1)
Race (White) 48 (90.5)
Handedness (Right) 44 (83.0)
ECOG PS
 0 26 (49.1)
 1 26 (49.1)
 2 1 (1.9)
 3 0 (0)
 4 0 (0)
Education
 High school or less 16 (30.8)
 College/Vocational 23 (44.2)
 Graduate 13 (25.0)
Tumor Characteristics
Hemisphere Involved
 Bilateral 8 (15.4)
 Left 23 (44.2)
 Right 21 (40.4)
Brain Regions included in PTV
 Frontal lobe 15 (28.3)
 Temporal lobe 7 (13.2)
 Parietal lobe 4 (7.5)
 Occipital lobe 18 (34.0)
 Whole brain 10 (18.9)
 Hippocampus 10 (18.9)
Tumor Type
 Glioblastoma 4 (8)
 Anaplastic glioma 3 (6)
 Primitive neuroectiodermal 11 (21)
 Benign/Low-grade 35 (66)
Treatment Characteristics
Median Maximum RT Dose, cGy (range) 5400 (4000-6060)
Median Fractional Dose, cGy (range) 180.00 (150-200)

ECOG PS, Eastern Cooperative Oncology Group performance status; PTV, planning target volume; RT, radiation therapy.